Pharma news
Pharma
The practical implications of Brexit, including on the Unified Patent Court, were the focus of a roundtable discussion at Life Sciences Patent Network North America, an industry event. 31 August 2017
Pharma
The UK government has committed £160 million ($280.2 million) in funding to the life sciences after a review of the industry. 30 August 2017
Americas
Inter partes reviews filed by generic drug companies have a higher institution rate but lower invalidation rate compared to other IPRs, say Wenhua Yu, Stephen Maebius and Tianran Yan of Foley & Lardner. 30 August 2017
Pharma
With Brexit negotiations well under way, Nicola Dagg, global head of IP at Allen & Overy, says ensuring that all of the regulatory and compliance requirements are in place immediately after Britain leaves the EU is the most important aspect of negotiations for the life sciences. 25 August 2017
Americas
Brazil’s Ministry of Health has published the entire list of the 2017 proposals to be considered for the Partnership for Product Development. 25 August 2017
Pharma
Pharmaceutical company AbbVie’s attempt to obtain an extension on its Humira patents has been rejected by an Australian court. 24 August 2017
Americas
The biggest challenges in the life sciences concern second medical use patents and incentives for innovation, according to Lydia McNally, vice president, head of patents, oncology at Novartis. 23 August 2017
Asia-Pacific
Samsung’s biopharmaceutical arm Samsung Bioepis has agreed a deal with Takeda to tackle “unmet disease areas”, marking the South Korean company’s move into the novel drugs market. 22 August 2017
Americas
Mylan has finalised a $465 million payment to the US government to settle a lawsuit about the classification of EpiPen Auto-Injector (epinephrine) under the Medicaid Drug Rebate Program. 18 August 2017
Americas
Two US House Representatives have begun an investigation into the pricing of drugs used to treat multiple sclerosis. 18 August 2017